Skip to main content

Table 3 Distribution of cardiovascular risk categories and estimated costs associated with treatment of hypertension, dyslipidemia and diabetes mellitus

From: Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy

      Cost
      2004 2005
Condition/criterion Associated conditions Risk* Medication Prevalence in population aged 25–64 (%) Cost per day per treated patient (SCR) Annual cost for all cases aged ≥25 yrs (SCR million) Per capita cost for total population per year (US$) Cost per day per treated patient (SCR) Annual cost for all cases aged ≥25 yrs (SCR million) Per capita cost for total population per year (US$)
Diabetes (DM)           
FBG ≥10 mmol/l   High Metformin 1.5 g/d & Glibenclamide 10 mg/d 4.9 6.05 4.95 12.4 0.66 0.54 1.3
    Addition of insulin 20 U (in 10% of cases)   3.40 0.28 0.7 7.72 0.63 1.6
FBG 7–9 mmol/l   High Metformin 1.5 g/d 3.6 4.83 2.92 7.3 0.48 0.29 0.7
FBG <7 mmol/l Treatment for DM High Metformin 1 g/d 0.9 3.19 0.45 1.1 0.32 0.05 0.1
Total diabetes     9.3   8.60 21.5   1.51 3.8
Hypertension           
≥180/110 mmHg - High 2 drugs (20%), 3 drugs (70%), 4 drugs (10%) 3.1 4.10 2.11 5.3 1.47 0.76 1.9
160–179/100–109 ≥3 MRF or DM High 2 drugs (60%), 3 drugs (30%), 4 drugs (10%) 2.3 3.47 1.33 3.3 1.26 0.48 1.2
160–179/100–109 0–2 MRF, not DM Medium 1 drug (10%), 2 drugs (60%), 3 drugs (30%) 5.6 2.78 2.63 6.6 1.01 0.96 2.4
140–159/90–99 ≥3 MRF or DM High 1 drug (20%), 2 drugs (70%), 3 drugs (10%) 5.6 2.27 2.14 5.4 0.83 0.79 2.0
140–159/90–99 1–2 MRF, not DM Medium 1 drug (60%), 2 drugs (40%) 12.1 1.32 2.67 6.7 0.50 1.01 2.5
140–159/90–99 0 MRF Low - 4.3 0    0   
<140/90 Treatment and ≥1 MRF ≥Medium 1 drug (70%), 2 drugs (30%) 6.9 1.12 1.28 3.2 0.43 0.49 1.2
Total hypertension     39.9   12.16 30.4   4.48 11.2
High cholesterol           
≥8 mmol/l   High Rosuvastatin 10 mg/d (80%), 20 mg (20%) 3.1 9.37 4.80 12.0 8.77 4.49 11.2
7–7.9 mmol/l ≥2 MRF or DM High Rosuvastatin 10 mg/d 3.5 7.81 4.56 11.4 7.31 4.27 10.7
6–6.9 mmol/l ≥3 MRF or DM High Rosuvastatin 10 mg/d 2.8 7.81 3.71 9.3 7.31 3.47 8.7
Total dyslipidemia     9.4   13.07 32.7   12.24 30.6
Any condition     42.7   33.8 84.6   18.22 45.6
  1. *CVD risk assessed based on following risk factors: age ≥55 for men; smoking; total cholesterol ≥6.2 mmol/l (240 mg/dl); HDL-cholesterol <1.0 mmol/l (40 mg/dl), BP ≥140/90 mmHg or treatment, obesity (body mass index ≥30 kg/m2); SCR: Seychelles rupees.